BioMarin
0 followers
BMRN
Performance
About BioMarin
BioMarin is a global biotechnology company that develops medicines to treat rare genetic conditions and lysosomal storage diseases. The company focuses on therapies for conditions such as achondroplasia and severe hemophilia A, with a broad portfolio of eight marketed products and an advancing pipeline across research and development, manufacturing, and clinical trials. Since its founding in 1997, BioMarin has established a worldwide presence and ongoing patient support programs, with operations and information accessible to patients and healthcare professionals globally.
Recent News
Recent Deals
No recent deals for this company.